Polish Academy of Sciences   Report issue

Government Phase 1 Phase 3
Founded: Warsaw Poland (1951)

Organization Overview

First Clinical Trial
2005
NCT00693680
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Institute of Immunology and Experimental Therapy of the Polish Academy of Sciences | Mossakowski Medical Research Centre Polish Academy of Sciences | Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences | Polish Academy of Sciences

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Amyotrophic Lateral Sclerosis (Phase 1)

Drug Resistant Epilepsy (Phase 1)

Epilepsy (Phase 1)

Motor Neuron Disease (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 8
  • # of Trial APIs: 9